Completed NA Interventional 1-arm
NCT03859674
Firehorus Rapamycin Target Eluting Vertebral Artery Stent System in Clinical Application
A Prospective, Multicenter, Single-Arm, Objective Performance Criteria-Clinical Study: Evaluation for Safety and Efficacy of Firehorus Rapamycin Target Eluting Vertebral Artery Stent System in Clinical Application
Sponsor: Beijing Tiantan Hospital
Conditions
Drug Eluting Stent Vertebral Artery Stenosis
Interventions
Firehorus
Updated 1 time since 2019 Last updated: Feb 28, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Drug Eluting Stent and Vertebral Artery Stenosis and is currently completed. Beijing Tiantan Hospital leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Completed — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Beijing Tiantan Hospital
- China National Center for Cardiovascular Diseases
- MicroPort NeuroTech Co., Ltd.
- Qilu Hospital of Shandong University
- RenJi Hospital
- Southwest Hospital, China
- Tang-Du Hospital
- Xinqiao Hospital of Chongqing
Data source: MicroPort NeuroTech Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.